High-risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study

被引:14
|
作者
Miranda, Angelica E. [1 ]
Silveira, Mariangela F. [2 ]
Travassos, Ana G. [3 ]
Tenorio, Teresinha [4 ]
Val, Isabel C. C. [5 ]
Lannoy, Leonor [6 ]
Mattos Junior, Hortensio S. [7 ]
Carvalho, Newton S. [8 ]
机构
[1] Univ Fed Espirito Santo, Vitoria, Brazil
[2] Univ Fed Pelotas, Pelotas, Brazil
[3] Univ Estadual Bahia, Salvador, BA, Brazil
[4] Univ Fed Pernambuco, Recife, PE, Brazil
[5] Univ Fed Fluminense, Niteroi, RJ, Brazil
[6] Unidade Saude Mista Asa Sul, Brasilia, DF, Brazil
[7] Lab Sao Marcos, Vila Velha, Brazil
[8] Univ Fed Parana, Curitiba, Parana, Brazil
关键词
Brazil; cervical cancer; HIV; HPV; women; INVASIVE CERVICAL-CANCER; SQUAMOUS-CELL CARCINOMA; LESIONS; HIV; PREVALENCE; PRECANCER; COUNTRIES; HIV/AIDS; DISEASE; UTILITY;
D O I
10.1002/jmv.24906
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cervical cancer is an important health issue in Latin America. Although HPV infections can have spontaneous clearance, persistence of high-risk (HR) HPV is a risk factor for cervical cancer among women and it is even higher in HIV-infected women. To determine the prevalence of HR-HPV and risk factors among HIV-infected women attending reference services for HIV/AIDS in different regions of Brazil. Cross-sectional study conducted among HIV-infected women attended at referral care centers for HIV/AIDS in nine states of Brazil. Women from 18 to 49 years that accept to participate and were not pregnant at the time of the approach were recruited for the study. The HPV screening was realized using qPCR in closed system, in vitro Diagnostic, COBAS (R)-HPV Roche. The cytology results were available by the Bethesda System. A total of 802(89.1%) from the selected women agreed to participate in the study. Median age was 39(Inter quartile range [IQR34-46]) years and median education was 9(IQR6-11) years. General prevalence of HR-HPV was 28.4%(228/802). HPV-16 prevalence rate was 8.1%(65/802), HPV-18 was 3.7%(30/802) and other types of HR-HPV were 23.6% (189/802). Risk factors for HR-HPV infection in the multivariate logistic regression analysis were: age ranging from 18 to 34 years (OR = 1.43[95%CI:1.18-1.75]), illicit drugs use (OR = 1.61[95%CI:1.10-2.42]) and abnormal cervical cytology (OR = 1.56[95%CI:1.34-1.81]). Results showed a prevalence rate of 28.4% of HR-HPV infection in women living with HIV in Brazil. These infections were significantly associated with having less than 35 years old, illicit drug use and abnormal cervical cytology.
引用
收藏
页码:2217 / 2223
页数:7
相关论文
共 50 条
  • [31] Human immunodeficiency virus epidemic scenery among brazilian women: a spatial analysis study
    Ana Luisa Lemos Bezerra
    Paula Regina Barbosa de Almeida
    Renata Karina Reis
    Glenda Roberta Oliveira Naiff Ferreira
    Fabianne de Jesus Dias de Sousa
    Elucir Gir
    Eliã Pinheiro Botelho
    BMC Women's Health, 23
  • [32] Human immunodeficiency virus epidemic scenery among brazilian women: a spatial analysis study
    Bezerra, Ana Luisa Lemos
    de Almeida, Paula Regina Barbosa
    Reis, Renata Karina
    Ferreira, Glenda Roberta Oliveira Naiff
    de Sousa, Fabiana de Jesus Dias
    Gir, Elucir
    Botelho, Elia Pinheiro
    BMC WOMENS HEALTH, 2023, 23 (01)
  • [33] Vaginal Bacteria and Risk of Incident and Persistent Infection With High-Risk Subtypes of Human Papillomavirus: A Cohort Study Among Kenyan Women
    Carter, Kayla A.
    Srinivasan, Sujatha
    Fiedler, Tina L.
    Anzala, Omu
    Kimani, Joshua
    Mochache, Vernon
    Wallis, Jacqueline M.
    Fredricks, David N.
    McClelland, R. Scott
    Balkus, Jennifer E.
    SEXUALLY TRANSMITTED DISEASES, 2021, 48 (07) : 499 - 507
  • [34] Human papillomavirus prevalence in pregnant women living with human immunodeficiency virus infection: a scoping review of the literature
    Metz, Charlotte Kalinka
    Skof, Anna Sophie
    Henrich, Wolfgang
    Sehouli, Jalid
    Kaufmann, Andreas M.
    Rohr, Irena
    JOURNAL OF PERINATAL MEDICINE, 2024, 52 (01) : 1 - 13
  • [35] Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area
    Belglaiaa, Essaada
    Elannaz, Hicham
    Mouaouya, Bouchra
    Aksim, Mohamed
    Mercier, Mariette
    Pretet, Jean-Luc
    Chouham, Said
    Mougin, Christiane
    INFECTIOUS AGENTS AND CANCER, 2015, 10
  • [36] Prevalence of high-risk human papillomavirus infection among women in Shaanxi province of China: A hospital-based investigation
    Cao, Di
    Zhang, Shaohua
    Zhang, Qian
    Wei, Xing
    Zhao, Minyi
    Ma, Qian
    Li, Yang
    Wang, Li
    Pei, Meili
    Yang, Ting
    Zhao, Juan
    Yang, Xiaofeng
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (07) : 1281 - 1286
  • [37] A Six-Year Gynecological Follow-Up of Immunosuppressed Women with a High-Risk Human Papillomavirus Infection
    Wielgos, Aleksandra
    Pietrzak, Bronislawa
    Suchonska, Barbara
    Sikora, Mariusz
    Rudnicka, Lidia
    Wielgos, Miroslaw
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (06)
  • [38] Twelve-Year Trend in the Prevalence of High-Risk Human Papillomavirus Infection Among Rwandan Women Living With HIV
    Murenzi, Gad
    Kanyabwisha, Faustin
    Murangwa, Anthere
    Kubwimana, Gallican
    Mutesa, Leon
    Burk, Robert D.
    Anastos, Kathryn
    Castle, Philip E.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (01) : 74 - 81
  • [39] The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China
    Zhang, Hong-Yun
    Fei, Man-Dong
    Jiang, Yong
    Fei, Qiu-Yue
    Qian, Hong
    Xu, Lin
    Jin, Yu-Ni
    Jiang, Cheng-Qin
    Li, Hai-Xia
    Tiggelaar, Sarah M.
    Smith, Jennifer S.
    Sahasrabuddhe, Vikrant V.
    Qiao, You-Lin
    VIROLOGY JOURNAL, 2014, 11
  • [40] Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus
    Luckett, Rebecca
    Mogowa, Neo
    Li, Howard J.
    Erlinger, Adrienne
    Hacker, Michele R.
    Esselen, Katharine
    Feldman, Sarah
    Shapiro, Roger
    Morroni, Chelsea
    Ramogola-Masire, Doreen
    OBSTETRICS AND GYNECOLOGY, 2019, 134 (04) : 840 - 849